Homogeneous proximity tyrosine kinase assays: Scintillation proximity assay versus homogeneous time-resolved fluorescence

被引:101
作者
Park, YW [1 ]
Cummings, RT [1 ]
Wu, L [1 ]
Zheng, S [1 ]
Cameron, PM [1 ]
Woods, A [1 ]
Zaller, DM [1 ]
Marcy, AI [1 ]
Hermes, JD [1 ]
机构
[1] Merck Res Labs, Dept Mol Design & Divers, Rahway, NJ 07065 USA
关键词
D O I
10.1006/abio.1999.4029
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Two homogeneous proximity assays for tyrosine kinases, scintillation proximity assay (SPA) and homogeneous time-resolved fluorescence (HTRF), have been developed and compared. In both formats, the kinase assay was performed using biotinylated peptide substrate, ATP ([P-33]ATP in the case of SPA), and tyrosine kinase in a 96-well assay format. After the kinase reaction was stopped, streptavidin-coated SPA beads or europium cryptate-labeled anti-phosphotyrosine antibody and streptavidin-labeled allophycocyanin were added as detection reagents for SPA or HTRF assays, respectively. Since the assay signal was detected only when the energy donor (radioactivity for SPA, Eu for HTRF) and the energy acceptor molecules (SPA beads for SPA, allophycocyanin for HTRF) were in close proximity, both assays required no wash or liquid transfer steps. This homogeneous ("mix-and-measure") nature allows these assays to be much simpler, more robust, and easier to automate than traditional protein kinase assays, such as a filter binding assay or ELISA. Both assays have been miniaturized to a 384-well format to reduce the assay volume, thereby saving the valuable screening samples as well as assay reagents, and automated using automated pipeting stations to increase the assay throughput. Several advantages and disadvantages for each assay are described. (C) 1999 Academic Press.
引用
收藏
页码:94 / 104
页数:11
相关论文
共 23 条
[1]   BINDING OF COENZYME ANALOGS TO LACTOBACILLUS-CASEI DIHYDROFOLATE-REDUCTASE - BINARY AND TERNARY COMPLEXES [J].
BIRDSALL, B ;
BURGEN, ASV ;
ROBERTS, GCK .
BIOCHEMISTRY, 1980, 19 (16) :3723-3731
[2]   SITE-SPECIFICITY OF P72(SYK) PROTEIN-TYROSINE KINASE - EFFICIENT PHOSPHORYLATION OF MOTIFS RECOGNIZED BY SRC HOMOLOGY-2 DOMAINS OF THE SRC FAMILY [J].
BRUNATI, AM ;
DONELLADEANA, A ;
RUZZENE, M ;
MARIN, O ;
PINNA, LA .
FEBS LETTERS, 1995, 367 (02) :149-152
[3]   Scintillation proximity assay: A versatile high-throughput screening technology [J].
Cook, ND .
DRUG DISCOVERY TODAY, 1996, 1 (07) :287-294
[4]  
CUMMINGS RT, 1999, IN PRESS ANAL BIOCH
[5]   Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor - Study of Lck- and FynT-dependent T cell activation [J].
Hanke, JH ;
Gardner, JP ;
Dow, RL ;
Changelian, PS ;
Brissette, WH ;
Weringer, EJ ;
Pollok, K ;
Connelly, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :695-701
[6]   THE PROTEIN-KINASE FAMILY - CONSERVED FEATURES AND DEDUCED PHYLOGENY OF THE CATALYTIC DOMAINS [J].
HANKS, SK ;
QUINN, AM ;
HUNTER, T .
SCIENCE, 1988, 241 (4861) :42-52
[7]   PROTEIN KINASES .6. THE EUKARYOTIC PROTEIN-KINASE SUPERFAMILY - KINASE (CATALYTIC) DOMAIN-STRUCTURE AND CLASSIFICATION [J].
HANKS, SK ;
HUNTER, T .
FASEB JOURNAL, 1995, 9 (08) :576-596
[9]   Tyrosine kinase assays adapted to homogeneous time-resolved fluorescence [J].
Kolb, AJ ;
Kaplita, PV ;
Hayes, DJ ;
Park, YW ;
Pernell, C ;
Major, JS ;
Mathis, G .
DRUG DISCOVERY TODAY, 1998, 3 (07) :333-342
[10]  
Kolb J.M., 1996, J BIOMOL NMR, V1, P203